3.5.1.15: aspartoacylase
This is an abbreviated version!
For detailed information about aspartoacylase, go to the full flat file.
Word Map on EC 3.5.1.15
-
3.5.1.15
-
canavan
-
n-acetylaspartate
-
leukodystrophy
-
matter
-
myelin
-
oligodendrocyte
-
spongy
-
n-acetyl-l-aspartate
-
spongiform
-
macrocephaly
-
tremor
-
ashkenazi
-
jewish
-
non-jewish
-
dysmyelination
-
nutrition
-
medicine
-
pharmacology
-
n-acetylaspartylglutamate
-
triacetate
- 3.5.1.15
- canavan
- n-acetylaspartate
- leukodystrophy
- matter
- myelin
- oligodendrocyte
-
spongy
- n-acetyl-l-aspartate
-
spongiform
- macrocephaly
- tremor
-
ashkenazi
-
jewish
-
non-jewish
-
dysmyelination
- nutrition
- medicine
- pharmacology
- n-acetylaspartylglutamate
- triacetate
Reaction
Synonyms
acetyl-aspartic deaminase, Acylase II, aminoacylase 2, Aminoacylase II, aminoacylase-2, ASPA, aspartic acid acylase, Aspartoacylase, aspartoacylase II, hASPA, human ASPA, More, murine aspartoacylase, N-acetyl-aspartate deacetylase, N-Acetyl-L-aspartate amidohydrolase, N-Acetylaspartate amidohydrolase, N-acetylaspartocylase, NAA acylase
ECTree
Advanced search results
Application
Application on EC 3.5.1.15 - aspartoacylase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
medicine
nutrition
-
development of a general and simple procedure for the resolution of racemic amino acids
pharmacology
the enzyme is the taget for treatment of Canavan disease, enzyme replacement therapy can potentially be used to overcome these defects if a stable enzyme form that can gain access to the appropriate neural cells can be produced. PEGylated form of aspartoacylase are able to traverse the blood-brain barrier and show dramatic enhancement in brain tissue access and distribution, overview. Examination of the effect of enzyme administration on the immunological response
-
diagnosis of Canavan disease, an autosomal recessive neurodegenerative disorder characterized by aspartoacylase deficiency, technique for prenatal diagnosis
medicine
-
mutations in the aspartoacylase aspA gene are implicated as the cause of Canavan Disease